A controlled clinical trial was conducted to assess the effectiveness of Oscillococcinum R in the... more A controlled clinical trial was conducted to assess the effectiveness of Oscillococcinum R in the trealment of patients with influenza-like: syndromes. 188 patients received the test drug and 184 patients were assigned to the placebo. Data were recorded by the participating physicians at the beginning of the;: treatment, after 48 hours and after 7-10 days. During the first few days. the patients recorded their rectal temper.:l.ture twice: a day (mornings and t::venings). t} symptoms on a rating scale (cough, catarrh, sore throat, muscle pain. t:tc.), and use of medication. Recovery was defined as follows: 'rectal tempernturc < 37.5°C and no headache or muscle pain', Etfectivene.')s was defined:1.., ... a statistically significant greater decrease in symptoms after 48 hours in the verum group or a shorter duration of symptoms in comparison to the placebo group. After 48 hours the symptoms of the patients in the yerum h'TOl1P were significantly milder (p == 0.023) than in the placebo group. The num ber of patients with no symptoms was signi~c:mtly higher in the verum group from the second day onwards (verum: 17.4%. placebo: 6.0%) until the end of the patients' recording (day 5 in the evening: verum: 73. 7%, placeho: 67.7%). The biggest group difference was recorded for the time between the evening of the second day (10.6% more patienrs with no symptoms) and the morning of the fourth day (W.2% more patients with no symptoms). The clinica.l trial showed that treatment ur influenza-like syndromes with Oscillococcinwn R has ;]. positive effect on the decline of symptOms and on the duration of the disease.
A controlled clinical trial was conducted to assess the effectiveness of Oscillococcinum R in the... more A controlled clinical trial was conducted to assess the effectiveness of Oscillococcinum R in the trealment of patients with influenza-like: syndromes. 188 patients received the test drug and 184 patients were assigned to the placebo. Data were recorded by the participating physicians at the beginning of the;: treatment, after 48 hours and after 7-10 days. During the first few days. the patients recorded their rectal temper.:l.ture twice: a day (mornings and t::venings). t} symptoms on a rating scale (cough, catarrh, sore throat, muscle pain. t:tc.), and use of medication. Recovery was defined as follows: 'rectal tempernturc < 37.5°C and no headache or muscle pain', Etfectivene.')s was defined:1.., ... a statistically significant greater decrease in symptoms after 48 hours in the verum group or a shorter duration of symptoms in comparison to the placebo group. After 48 hours the symptoms of the patients in the yerum h'TOl1P were significantly milder (p == 0.023) than in the placebo group. The num ber of patients with no symptoms was signi~c:mtly higher in the verum group from the second day onwards (verum: 17.4%. placebo: 6.0%) until the end of the patients' recording (day 5 in the evening: verum: 73. 7%, placeho: 67.7%). The biggest group difference was recorded for the time between the evening of the second day (10.6% more patienrs with no symptoms) and the morning of the fourth day (W.2% more patients with no symptoms). The clinica.l trial showed that treatment ur influenza-like syndromes with Oscillococcinwn R has ;]. positive effect on the decline of symptOms and on the duration of the disease.
Uploads
Papers by Gert Schuback